Abiopharma

Natera - Natera to Present 12 Datasets Including >50,000 Patients Featuring Signatera™ at the San Antonio Breast Cancer Symposium

Curaleaf Enters into an Equity Purchase Agreement for the Virginia Assets of The Cannabist Company

Oncotelic and Sapu Nano Unveils Broad-Applicability Deciparticle™ Nanomedicine Platform Capable of Formulating Multiple Hydrophobic Peptide, Macrolide, and Polyketide Drugs

Amneal to Participate in Upcoming Investor Conferences

Ensysce Biosciences Announces Broader Patent Protection for Groundbreaking MPAR(R) Overdose Protection Technology

Chemomab Therapeutics Announces Nebokitug Phase 2 SPRING Trial Results in Primary Sclerosing Cholangitis Published in the American Journal of Gastroenterology

Changes to the Composition of the Board and Board Committees

Change - Announcement of Appointment :: Appointment of Non-Independent Non-Executive Chairman

Clearmind Medicine Advances CMND-100 to Dosing Phase at Hadassah Medical Center in Ongoing Phase I/IIa Clinical Trial for Alcohol Use Disorder

Zoetis - Zoetis Highlights R&D Leadership and Long-Term Growth Opportunity at Innovation Webcast